![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Southwest Synthetic Pharmaceutical Corporation, Limited Chongqing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Hydrochlorothiazide, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2006-116 - Rev 00
This Chemical Type CEP, issued on January 18, 2008, remains in force until January 25, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 394 associated with this CEP further emphasizes